Sandu Pharmaceuticals share news, announcements and annual reports
BSE: 524703Pharmaceuticals & BiotechnologySmall Cap
Sandu Pharmaceuticals Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹35.95up ₹0.64 (1.81%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.31.
30 Oct: open ₹35.56, high ₹36.40, low ₹35.01
52-week range of traded prices to 30 Oct 2026
₹30.00Low, 30 Mar 2026₹50.00High, 27 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹35 Cr3,677th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.78%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,591
Sandu Pharmaceuticals disputes and clarifications
19 filed, newest first.
Feb 2025
Jun 2024
Jan 2022
3 Jan · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on January 03, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jun 2021
10 Jun · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on June 10, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Dec 2020
1 Dec · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on December 1, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Oct 2020
12 Oct · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on October 12, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Aug 2020
14 Aug · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on August 14, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jul 2020
1 Jul · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on July 1, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2020
22 Apr · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on April 22nd, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jan 2020
9 Jan · Legal
8 Jan · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on 08th January, 2020 with reference to significant movement in price, in order to ensure that investors have latest ....
Aug 2019
Jul 2019
31 Jul · Legal
Exchange has sought clarification from Sandu Pharmaceuticals Ltd on July 31, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....